NaNose Medical Israeli Company

Early screening and proactive care are the future of medicine. NaNose is revolutionizing disease detection and management with its cutting-edge breathomics technology. Uniquely designed for primary care settings, it leverages nanotechnology and AI to create breath "fingerprints" from volatile biomarkers, avoiding burdensome molecule concentration analysis.